NEWS & INSIGHTS

Latest News
Exscientia announces joint initiative to identify COVID-19 drugs with Diamond Light Source and Scripps Research
Read Now

All

Exscientia announces joint initiative to identify COVID-19 drugs with Diamond Light Source and Scripps Research

READ MORE

Financial Times : Read the article detailing Exscientia's work on the first AI-designed drug to enter clinical trials.

READ MORE

Sumitomo Dainippon Pharma and Exscientia Joint Development New Drug Candidate Created Using Artificial Intelligence (AI) Begins Clinical Trial

READ MORE

Exscientia appoints Dr. David Hallett as Chief Operating Officer as company positions for further growth

READ MORE

Bayer and Exscientia collaborate to leverage the potential of artificial intelligence in cardiovascular and oncology drug discovery

READ MORE

Sanofi Exercises option on Exscientia-designed bispecific small molecule for treatment of immunological conditions

READ MORE

Exscientia enters broad rare disease drug discovery collaboration with Rallybio

READ MORE

Exscientia expands international collaborations with Shanghai-headquartered GT Apeiron Therapeutics

READ MORE

Exscientia achieves molecule discovery milestone as part of GSK collaboration

READ MORE
  • <<
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • >>